Literature DB >> 34120126

Cervical Cancer Prevention in Low- and Middle-Income Countries.

Emma R Allanson1, Kathleen M Schmeler.   

Abstract

Cervical cancer is one of the commonest cancers afflicting women in low and middle income countries, however, both primary prevention with human papillomavirus vaccination, and secondary prevention with screening programs and treatment of preinvasive disease are possible. A coordinated approach to eliminating cervical cancer, as has been called for by the World Health Organization, requires a complex series of steps at all levels of a health system. This article outlines the current state of cervical cancer prevention in low and middle income countries, the innovations being employed to improve outcomes, and consideration of the next steps needed as we move towards global elimination.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34120126      PMCID: PMC8324570          DOI: 10.1097/GRF.0000000000000629

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   1.966


  93 in total

1.  Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings.

Authors:  Christopher T Lam; Marlee S Krieger; Jennifer E Gallagher; Betsy Asma; Lisa C Muasher; John W Schmitt; Nimmi Ramanujam
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

2.  Human papillomavirus vaccines: WHO position paper, October 2014.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2014-10-24

3.  Feasibility of implementing cervical cancer screening program using smartphone imaging as a training aid for nurses in rural India.

Authors:  Drishti Sharma; Latika Rohilla; Rashmi Bagga; Radhika Srinivasan; Har Ashish Jindal; Nikita Sharma; Ankita Kankaria; Limalemla Jamir; Vanita Suri; Rakesh Kumar Singh; Mona Duggal
Journal:  Public Health Nurs       Date:  2018-05-28       Impact factor: 1.462

4.  Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.

Authors:  Hanna Bergman; Brian S Buckley; Gemma Villanueva; Jennifer Petkovic; Chantelle Garritty; Vittoria Lutje; Alina Ximena Riveros-Balta; Nicola Low; Nicholas Henschke
Journal:  Cochrane Database Syst Rev       Date:  2019-11-22

5.  Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study.

Authors:  Louise Kuhn; Rakiya Saidu; Rosalind Boa; Ana Tergas; Jennifer Moodley; David Persing; Scott Campbell; Wei-Yann Tsai; Thomas C Wright; Lynette Denny
Journal:  Lancet Glob Health       Date:  2020-02       Impact factor: 26.763

6.  World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.

Authors:  Nancy Santesso; Reem A Mustafa; Holger J Schünemann; Marc Arbyn; Paul D Blumenthal; Joanna Cain; Michael Chirenje; Lynette Denny; Hugo De Vuyst; Linda O'Neal Eckert; Sara E Forhan; Eduardo L Franco; Julia C Gage; Francisco Garcia; Rolando Herrero; José Jeronimo; Enriquito R Lu; Silvana Luciani; Swee Chong Quek; Rengaswamy Sankaranarayanan; Vivien Tsu; Nathalie Broutet
Journal:  Int J Gynaecol Obstet       Date:  2015-12-14       Impact factor: 3.561

7.  Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.

Authors:  Kabelo M B Lekoane; Desmond Kuupiel; Tivani P Mashamba-Thompson; Themba G Ginindza
Journal:  BMC Cancer       Date:  2019-06-11       Impact factor: 4.430

Review 8.  Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus.

Authors:  Zheng Quan Toh; Jennie Kosasih; Fiona M Russell; Suzanne M Garland; Edward K Mulholland; Paul V Licciardi
Journal:  Infect Drug Resist       Date:  2019-07-04       Impact factor: 4.003

9.  Evaluation of stationary colposcope and the Gynocular, by the Swede score systematic colposcopic system in VIA positive women: a crossover randomized trial.

Authors:  Ashrafun Nessa; Charlotte Wistrand; Shirin Akter Begum; Marcus Thuresson; Isaac Shemer; Malin Thorsell; Elisabeth Andrea Wikström Shemer
Journal:  Int J Gynecol Cancer       Date:  2014-02       Impact factor: 3.437

10.  Real-Time Monitoring and Evaluation of a Visual-Based Cervical Cancer Screening Program Using a Decision Support Job Aid.

Authors:  Curtis W Peterson; Donny Rose; Jonah Mink; David Levitz
Journal:  Diagnostics (Basel)       Date:  2016-05-16
View more
  1 in total

Review 1.  Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination.

Authors:  Flávia M Corrêa; Arn Migowski; Liz M de Almeida; Marcelo A Soares
Journal:  Front Med (Lausanne)       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.